A Chimpanzee Genome Project Is a Biomedical Imperative: Figure B1.
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
A near-complete sequence of the human genome is now available, and many efforts are currently focused on the next logical biomedically relevant target — the mouse genome. Given limited resources, which vertebrate genome(s) should be tackled after that? Reasonable candidates include other well-studied model organisms such as Rattus rattus (the rat), Xenopus laevis (the African clawed toad), and Danio rerio (the zebra fish). Over the last few years, some have been advocating a genomic approach toward understanding our closest evolutionary relatives, the great apes (McConkey and Goodman 1997; Paabo 1999; McConkey et al., 2000). Pan troglodytes (the chimpanzee) and Pan paniscus (the bonobo) share nearly 99% of human genomic sequences (see Box 1 for discussion) (King and Wilson 1975; Sibley and Ahlquist 1984; Caccone and Powell 1989; Ruvolo 1997; Goodman et al. 1998; Satta et al. 2000). Thus, it is cogently argued that knowing the complete genome of at least one of these species will give us a window into genes that contribute to humaness (the chimpanzee is the first choice, because we know more about this species than we do about the bonobo). The emergence of humans can be regarded as one of the major transitions in evolution (Szathmary and Smith 1995), and the complete explanation of this phenomenon ranks as one of the greatest unsolved mysteries of science. Taxpaying citizens might argue that, given limited resources, this lofty and anthropocentric pursuit should not take precedence over the pragmatic value of sequencing genomes of model organisms that have already been better studied by a variety of biomedical and genetic approaches. Moreover, it might be suggested that this is a matter for the National Science Foundation (NSF) to deal with, not the National Institutes of Health (NIH). Programs within the NSF are currently considering a Human Origins Initiative (Weiss and Yellen 2000). However, I would like to suggest that there is clear and compelling biomedical value to giving high priority to the complete sequencing of the chimpanzee genome and that of at least one Old World monkey. The experience of primate centers and zoos over the last century indicates that there are many interesting differences in disease frequency and severity between humans and great apes such as the chimpanzee. Whereas the evidence is sometimes fragmentary or inconclusive, the nature and significance of these medical conditions (including AIDS, Alzheimer’s disease (AD), cancer, malaria, and perimenopausal complications) are sufficient to draw attention to the issue. After all, extrapolating findings in physiology and pathology from mice, rats, toads, or fish to humans can be difficult, because of our significant physiological and genetic differences from these species. In contrast, the >99% identity of amino acid sequences of most chimpanzee and human proteins (see Box 1) predict a stronger likelihood of finding genetic explanations for any disease differences. Studies of the chimpanzee genome could be considered a logical extension of the current emphasis on exploiting sequence differences between various human groups to identify important disease susceptibility genes. For this and other reasons, the cost of a chimpanzee genome project should also be much less than for the original Human Genome Project. Also, as discussed below, the knowledge gained could be of much value in our efforts to conserve and care for the great apes themselves. Some pathological states in humans seem to represent the normal situation in chimpanzees, including craniosynostosis (closure of the skull sutures in the perinatal period) (Cohen 1991), general leukocytosis (a high white blood cell count) (Hodson et al. 1967; McClure et al. 1972) and extensive hypertrichosis (hairiness). Several other diseases or physiological states of humans appear to be rare or markedly attenuated in the chimpanzee (Scott 1992). Some of these diseases can be attributed to anatomic differences between the species, including protracted, painful, and dangerous childbirth (resulting from the larger head of the human fetus and the altered pelvis of the bipedal human female), neonatal cephalhematoma (the common subperiosteal blood clot of the new born human skull bones), wisdom tooth impaction (resulting from the reduced jaw size in humans and the lack of a post-molar gap), and various diseases attributed to gravity effects on bipedal humans (vertebral osteoarthritis, intervertebral disc protrusion, varicose veins, and hemorrhoids). There are also a few anatomically unique diseases of great apes that do not occur in humans, such as infection of the pharyngeal air sacs (an organ that is absent in humans) (Strobert and Swenson 1979). The rarity of certain other human conditions such as sexually transmitted diseases and severe hypercholesterolemia in great apes is possibly explained on a behavioral/ cultural basis, as they can be induced experimentally in the latter (Scott 1992). The h
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
King, M.-C., & Wilson, A. C. (1975) · Science · doi:10.1126/science.1090005 · Cited by 2,815
The major evolutionary transitions
Szathmáry, E., & Smith, J. M. (1995) · Nature · doi:10.1038/374227a0 · Cited by 1,095
Goodman, M., Porter, C. A., Czelusniak, J., Page, S. L., Schneider, H., Shoshani, J., Gunnell, G., & Groves, C. P. (1998) · Molecular Phylogenetics and Evolution · doi:10.1006/mpev.1998.0495 · Cited by 743
Diagnostic Criteria for Neuropathologic Assessment of Alzheimer’s Disease
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00062-6 · Cited by 410
Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease.
Gearing, M., Rebeck, G. W., Hyman, B. T., Tigges, J., & Mirra, S. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9382 · Cited by 179
Prevalence, incidence and duration of Braak's stages in the general population: can we know?
Duyckaerts, C., & Hauw, J.-J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00047-x · Cited by 109
Cited by
Intra- and Interspecific Variation in Primate Gene Expression Patterns
Enard, W., Khaitovich, P., Klose, J., Zöllner, S., Heissig, F., Giavalisco, P., Nieselt-Struwe, K., Muchmore, E., Varki, A., Ravid, R., et al. (2002) · Science · doi:10.1126/science.1068996 · Cited by 845
Self-citationGrandmothers and the evolution of human longevity
Hawkes, K. (2003) · American Journal of Human Biology · doi:10.1002/ajhb.10156 · Cited by 582
“In addition to the essential value of those and other behavioral comparisons between these species (e.g., de Waal 2001), genetic comparisons now promise the possibility of detailed evidence about human evolution (Varki, 2000; Gagneux and Varki, 2001; Enard et al., 2002).”
BackgroundFrom evolutionary genetics to human immunology: how selection shapes host defence genes
Barreiro, L. B., & Quintana-Murci, L. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2698 · Cited by 558
Siglecs—the major subfamily of I-type lectins
Varki, A., & Angata, T. (2006) · Glycobiology · doi:10.1093/glycob/cwj008 · Cited by 518
Self-citationForces shaping the fastest evolving regions in the human genome
Pollard, K. S., Salama, S. R., King, B., Kern, A. D., Dreszer, T., Katzman, S., Siepel, A., Pedersen, J. S., Bejerano, G., Baertsch, R., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020168 · Cited by 511
Metadata
- Authors
- Varki, A.
- Venue
- Genome Research
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-08-01
- Volume
- 10
- Issue
- 8
- Pages
- 1065-1070
- ISSN
- 1088-9051 (ISSN-L)
- 1549-5469
- OpenAlex
- W2069567682
- Cited by
- 102
- References
- 6
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.